TheraRadar

Pharma Intelligence, Simplified

Landscape → CNS

PTSD

183 clinical trials

74 active
/
183 total (since 2015)
14
Phase 1 Active
40 total
44
Phase 2 Active
111 total
11
Phase 3 Active
37 total
9
Phase 4 Active
22 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Oui Therapeutics, Inc. 2 0 0
Senseye, Inc. 1 0 0
Otsuka Medical Devices Co., Ltd. Japan 1 0 0
Reconnect Labs 1 0 0
Nyree Penn 1 0 0
Lykos Therapeutics 0 6 3
Tonix Pharmaceuticals, Inc. 0 2 4
NCT07280065 RECRUITING
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Senseye, Inc. n=1,900
NCT07418554 NOT YET RECRUITING
Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin
University Hospital, Strasbourg, France n=120
NCT03539614 ACTIVE NOT RECRUITING
Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests
VA Office of Research and Development n=87
NCT06589505 RECRUITING
Software as a Medical Device for the Treatment of Patients With PTSD
Otsuka Medical Devices Co., Ltd. Japan n=52
NCT07167940 NOT YET RECRUITING
Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days
VA Office of Research and Development n=90
NCT05427500 ENROLLING BY INVITATION
Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder
The Royal's Institute of Mental Health Research n=54
NCT06117306 RECRUITING
MDMA-assisted Massed Prolonged Exposure for PTSD
Healing Breakthrough n=20
NCT04877093 RECRUITING
Repurposing Low-Dose Clonidine for PTSD in Veterans
Wake Forest University Health Sciences n=32
NCT05637879 RECRUITING
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
White River Junction Veterans Affairs Medical Center n=92
NCT06394284 RECRUITING
Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury
Herzog Hospital n=60
NCT04985344 RECRUITING
Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol
University Hospital, Toulouse n=92
NCT04192266 COMPLETED
Estrogen and Fear in PTSD
The University of Texas Health Science Center, Houston n=83
NCT05979844 COMPLETED
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
Dr. Leslie Morland n=16
NCT05243459 TERMINATED
Testing the Efficacy of an Eye-tracking-based Treatment in Reducing Stress-related Symptoms in Veterans With PTSD
Tel Aviv University n=121
NCT03827057 COMPLETED
RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD)
Uniformed Services University of the Health Sciences n=94
NCT03537014 COMPLETED
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Lykos Therapeutics n=100
NCT04714359 COMPLETED
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Lykos Therapeutics n=87
NCT04077437 COMPLETED
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Lykos Therapeutics n=121
NCT03841773 TERMINATED
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD
Tonix Pharmaceuticals, Inc. n=192
NCT03110575 TERMINATED
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
Tonix Pharmaceuticals, Inc. n=190
NCT03508700 COMPLETED
A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD
Tonix Pharmaceuticals, Inc. n=93
NCT05446857 COMPLETED
Glecaprevir/Pibrentasvir for the Treatment of PTSD
White River Junction Veterans Affairs Medical Center n=10
NCT03062540 TERMINATED
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Tonix Pharmaceuticals, Inc. n=358
NCT02884908 COMPLETED
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD
University of Maryland, Baltimore n=57
NCT02187224 COMPLETED
Progesterone Effect on Individuals Diagnoses With AD and PTSD.
Yale University n=13
NCT05181995 TERMINATED
Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD
Aptinyx n=121
NCT02789982 COMPLETED
Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study
Assistance Publique - Hôpitaux de Paris n=364
NCT03216356 WITHDRAWN
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
Boston University Charles River Campus
NCT03151681 COMPLETED
The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol
Douglas Mental Health University Institute n=84
NCT04592159 WITHDRAWN
Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
Jazz Pharmaceuticals
NCT02992899 COMPLETED
Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder
Emory University n=56
NCT02397889 COMPLETED
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
Icahn School of Medicine at Mount Sinai n=30
NCT04322968 COMPLETED
Ketamine Infusion for Comorbid PTSD and Chronic Pain
VA Ann Arbor Healthcare System n=41
NCT04393818 COMPLETED
Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19
Fundació d'investigació Sanitària de les Illes Balears n=560
NCT03765138 TERMINATED
Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression
Research Foundation for Mental Hygiene, Inc. n=1
NCT02615197 COMPLETED
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
University of Washington n=35
NCT02737488 TERMINATED
Helping Children With Trauma
NYU Langone Health n=14

Data: ClinicalTrials.gov